Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jennifer Lynn

Ophthalmology Ardmore, PA Medical Doctor

NPI 1659390482 CMS profile 120848

100 Church Rd, Ardmore, PA 19003

Open in the dashboard

General payments

$4,594

163 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Lynn of Ardmore, PA is reported in the CMS Open Payments database as having received $4,594 across 163 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,041 26
2024 General $907 40
2023 General $691 28
2022 General $563 26
2021 General $267 12
2020 General $234 12
2019 General $890 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Lynn
  • Ophthalmology median
  • Middle half of Ophthalmology
  • National median

In program year 2025, general payments to Jennifer Lynn were reported at $1,041. Among 13,034 Ophthalmology profiles paid that year, the median was $384 and the middle half received between $136 and $917.

Show as a table
Year Jennifer Lynn Ophthalmology median Middle half National median
2019 $890 $258 $104–$655 $163
2020 $234 $126 $45–$321 $114
2021 $267 $205 $76–$534 $132
2022 $563 $266 $100–$678 $149
2023 $691 $308 $117–$745 $160
2024 $907 $340 $127–$846 $164
2025 $1,041 $384 $136–$917 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Oyster Point Pharma, Inc. $772 40 payments
  2. Sun Pharmaceutical Industries Inc. $704 25 payments
  3. AbbVie, Inc. $569 19 payments
  4. Novartis Pharmaceuticals Corporation $448 12 payments
  5. Tarsus Pharmaceuticals, Inc. $412 7 payments
  6. Bausch & Lomb Americas Inc. $315 11 payments
  7. Alcon Vision LLC $309 7 payments
  8. Allergan Inc. $243 7 payments
  9. Harrow Eye, LLC $132 5 payments
  10. Horizon Therapeutics plc $116 6 payments
  11. Other $574 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,582 162 payments
  2. Travel and Lodging $12 1 payment
Products named General payments · program years 2019–2025
  1. Cequa $680 24 payments
  2. TYRVAYA Dry Eye $491 20 payments
  3. LUMIGAN $432 13 payments
  4. XDEMVY $412 7 payments
  5. XIIDRA $365 14 payments
  6. TYRVAYA Dry eyes $280 20 payments
  7. Ryzumvi $249 18 payments
  8. VYZULTA $172 8 payments
  9. DURYSTA $160 2 payments
  10. RESTASIS $149 3 payments
  11. Other $1,799 59 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

890

Median for Ophthalmology: 891

Drug cost

$181,199

Median for Ophthalmology: $68,233

Branded share of claims

51.8%

Median for Ophthalmology: 29.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lumigan Bimatoprost Brand 114 $63,801
Restasis Cyclosporine Brand 43 $61,592
Cyclosporine Generic 33 $18,700
Alphagan P Brimonidine Tartrate Brand 30 $11,967
Travoprost Generic 33 $6,288
Combigan Brimonidine Tartrate/Timolol Brand 12 $5,612
Latanoprost Generic 274 $4,201
Brimonidine Tartrate Generic 13 $2,509
Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat Brand 132 $2,173
Tobramycin-Dexamethasone Tobramycin/Dexamethasone Brand 54 $2,104

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,260 Part D prescribers listed as Ophthalmology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 27 billing codes

Paid by Medicare

$200,670

Medicare's payments for the services billed

Medicare patients

850

Average age 76

Services billed

3,299

569 women, 281 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 48%
Ischemic heart disease 29%
Osteoporosis 26%
Cancer 20%
Diabetes 19%
Depression 19%
Chronic kidney disease 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LUMIGAN
  • AbbVie, Inc. $122
$122 114 —
TYRVAYA
  • Oyster Point Pharma, Inc. $121
$121 — —
Cequa
  • Sun Pharmaceutical Industries Inc. $119
$119 — —
VEVYE
  • Harrow Eye, LLC $101
$101 — —
MIEBO
  • Bausch & Lomb Americas Inc. $80
$80 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

163 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Ophthalmology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record